News + Resources
Keep up with the latest
Featured
Recent
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
This Scientist Is Building Custom Gene-Editing Tools
November 11, 2024
This Scientist Is Building Custom Gene-Editing Tools
November 11, 2024
Scribe Therapeutics to Present Preclinical Data on CRISPR Genome and Epigenome Editing Technologies at American Heart Association (AHA) Scientific Sessions 2024
October 30, 2024
Scribe Therapeutics to Present Preclinical Data on CRISPR Genome and Epigenome Editing Technologies at American Heart Association (AHA) Scientific Sessions 2024
October 30, 2024
All Stories
News
Sanofi taps Scribe for in vivo partnership worth more than $1.2B biobucks aimed at sickle cell and beyond
July 18, 2023
Fierce Biotech
Read Now
Press
Sanofi taps Scribe for in vivo partnership worth more than $1.2B biobucks aimed at sickle cell and beyond
July 18, 2023
Fierce Biotech
Read Now
News
East Bay's Scribe Therapeutics lands 2nd big deal with Sanofi, this one aimed initially at sickle cell disease
July 18, 2023
San Francisco Business Times
Read Now
Press
East Bay's Scribe Therapeutics lands 2nd big deal with Sanofi, this one aimed initially at sickle cell disease
July 18, 2023
San Francisco Business Times
Read Now
News
Sanofi expands collaboration with Scribe on CRISPR genome editing
July 18, 2023
Seeking Alpha
Read Now
Press
Sanofi expands collaboration with Scribe on CRISPR genome editing
July 18, 2023
Seeking Alpha
Read Now
News
Scribe Therapeutics and Sanofi collaborate on in vivo therapies for sickle cell disease
July 18, 2023
BioWorld
Read Now
Press
Scribe Therapeutics and Sanofi collaborate on in vivo therapies for sickle cell disease
July 18, 2023
BioWorld
Read Now